T1	Participants 153 236	individuals with serious mental illness (SMI) receiving antipsychotic drug therapy.
T2	Participants 479 512	individuals with SMI over 8 weeks
T3	Participants 522 554	0 individuals (BMI â‰¥ 28 kg/m(2))
